212 related articles for article (PubMed ID: 24312624)
1. Exendin-4 ameliorates traumatic brain injury-induced cognitive impairment in rats.
Eakin K; Li Y; Chiang YH; Hoffer BJ; Rosenheim H; Greig NH; Miller JP
PLoS One; 2013; 8(12):e82016. PubMed ID: 24312624
[TBL] [Abstract][Full Text] [Related]
2. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.
Li Y; Bader M; Tamargo I; Rubovitch V; Tweedie D; Pick CG; Greig NH
J Neurochem; 2015 Dec; 135(6):1203-1217. PubMed ID: 25982185
[TBL] [Abstract][Full Text] [Related]
3. Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice.
Rachmany L; Tweedie D; Li Y; Rubovitch V; Holloway HW; Miller J; Hoffer BJ; Greig NH; Pick CG
Age (Dordr); 2013 Oct; 35(5):1621-36. PubMed ID: 22892942
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 receptor agonist Exendin-4 improves neurological outcomes by attenuating TBI- induced inflammatory responses and MAPK activation in rats.
Zhang J; Yi T; Cheng S; Zhang S
Int Immunopharmacol; 2020 Sep; 86():106715. PubMed ID: 32570036
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes.
Kodera R; Shikata K; Kataoka HU; Takatsuka T; Miyamoto S; Sasaki M; Kajitani N; Nishishita S; Sarai K; Hirota D; Sato C; Ogawa D; Makino H
Diabetologia; 2011 Apr; 54(4):965-78. PubMed ID: 21253697
[TBL] [Abstract][Full Text] [Related]
6. Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats.
Xie Z; Enkhjargal B; Wu L; Zhou K; Sun C; Hu X; Gospodarev V; Tang J; You C; Zhang JH
Neuropharmacology; 2018 Jan; 128():142-151. PubMed ID: 28986282
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.
Perry T; Lahiri DK; Sambamurti K; Chen D; Mattson MP; Egan JM; Greig NH
J Neurosci Res; 2003 Jun; 72(5):603-12. PubMed ID: 12749025
[TBL] [Abstract][Full Text] [Related]
8. Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4.
Tweedie D; Rachmany L; Rubovitch V; Li Y; Holloway HW; Lehrmann E; Zhang Y; Becker KG; Perez E; Hoffer BJ; Pick CG; Greig NH
Alzheimers Dement; 2016 Jan; 12(1):34-48. PubMed ID: 26327236
[TBL] [Abstract][Full Text] [Related]
9. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.
Li Y; Perry T; Kindy MS; Harvey BK; Tweedie D; Holloway HW; Powers K; Shen H; Egan JM; Sambamurti K; Brossi A; Lahiri DK; Mattson MP; Hoffer BJ; Wang Y; Greig NH
Proc Natl Acad Sci U S A; 2009 Jan; 106(4):1285-90. PubMed ID: 19164583
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes.
Nielsen LL; Young AA; Parkes DG
Regul Pept; 2004 Feb; 117(2):77-88. PubMed ID: 14700743
[TBL] [Abstract][Full Text] [Related]
11. Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice.
Tweedie D; Rachmany L; Rubovitch V; Lehrmann E; Zhang Y; Becker KG; Perez E; Miller J; Hoffer BJ; Greig NH; Pick CG
Exp Neurol; 2013 Jan; 239():170-82. PubMed ID: 23059457
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of exendin-4 in rat model of spinal cord injury via inhibiting mitochondrial apoptotic pathway.
Li H; Jia Z; Li G; Zhao X; Sun P; Wang J; Fan Z; Lv G
Int J Clin Exp Pathol; 2015; 8(5):4837-43. PubMed ID: 26191175
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of exendin-4, a long-acting analogue of glucagon-like peptide-1 receptor agonist, on nerve regeneration after the crush nerve injury.
Yamamoto K; Amako M; Yamamoto Y; Tsuchihara T; Nukada H; Yoshihara Y; Arino H; Fujita M; Uenoyama M; Tachibana S; Nemoto K
Biomed Res Int; 2013; 2013():315848. PubMed ID: 23984340
[TBL] [Abstract][Full Text] [Related]
14. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S
J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064
[TBL] [Abstract][Full Text] [Related]
15. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats.
Darsalia V; Mansouri S; Ortsäter H; Olverling A; Nozadze N; Kappe C; Iverfeldt K; Tracy LM; Grankvist N; Sjöholm Å; Patrone C
Clin Sci (Lond); 2012 May; 122(10):473-83. PubMed ID: 22150224
[TBL] [Abstract][Full Text] [Related]
17. Induction of insulin receptor substrate-2 expression by Fc fusion to exendin-4 overexpressed in E. coli: a potential long-acting glucagon-like peptide-1 mimetic.
Kim JW; Kim K; Ahn Y; Jeong H; Jeong H; Ryu S; Lee S; Lee C; Chung HS; Jang SH
BMB Rep; 2010 Feb; 43(2):146-9. PubMed ID: 20193135
[TBL] [Abstract][Full Text] [Related]
18. Double-strand adeno-associated virus-mediated exendin-4 expression in salivary glands is efficient in a diabetic rat model.
Wang J; Wang F; Xu J; Ding S; Guo Y
Diabetes Res Clin Pract; 2014 Mar; 103(3):466-73. PubMed ID: 24438876
[TBL] [Abstract][Full Text] [Related]
19. Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.
Perry T; Haughey NJ; Mattson MP; Egan JM; Greig NH
J Pharmacol Exp Ther; 2002 Sep; 302(3):881-8. PubMed ID: 12183643
[TBL] [Abstract][Full Text] [Related]
20. Exenatide exerts cognitive effects by modulating the BDNF-TrkB neurotrophic axis in adult mice.
Bomba M; Granzotto A; Castelli V; Massetti N; Silvestri E; Canzoniero LMT; Cimini A; Sensi SL
Neurobiol Aging; 2018 Apr; 64():33-43. PubMed ID: 29331730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
